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entered into a database. Endovascular AAA repair was
reviewed over a 2-year interval, beginning in April 1998, at
the time of the initiation of our endovascular AAA program
in which commercially manufactured devices were used. All
patients receiving endovascular AAA repair after this date
were included. The records of patients with femorofemoral
bypass grafts were reviewed over the interval from
September 1994 to July 1999. Only the records of patients
receiving femorofemoral bypass grafts for arterial occlusive
disease or in conjunction with an aortomonoiliac endograft
for aneurysm disease were reviewed. Grafts placed for aor-
tic dissection and trauma, for example, were excluded from
the analysis. Statistical analysis was performed with Statview
statistical software (Abacus Concepts, Inc, Berkeley, Calif)
to perform life-table survival analysis.
RESULTS
Endovascular AAA repair
A total of 173 patients underwent endovascular AAA
repair over the 2-year interval. Graft manufacturers
included World Medical Talent (111), Ancure (31),
Medtronics AneuRx (25), Baxter Lifepath (4), and Cook
Zenith (2). Of these, 137 patients received bifurcated
grafts (ABG) and 36 underwent aortomonoiliac (AI)
grafts (33 World Medical Talent, 3 Ancure EVT) with
femorofemoral bypass grafting. All graft designs included
a fully stented endoskeleton or exoskeleton with the
exception of the Ancure EVT graft, which uses an unsup-
Endovascular repair of abdominal aortic aneurysms
(AAAs) is becoming increasingly prevalent. The devices
available for use are evolving as the technology continues to
improve. Various design concepts are currently being tested,
and as yet, no consensus has been reached as to which fea-
tures are optimal for a successful endovascular AAA repair.
Currently, designs with bifurcated endografts and aor-
tomonoiliac grafts combined with femorofemoral bypass
grafts are used. Fully supported graft limbs with a stented
endoskeleton or exoskeleton and unsupported grafts are
available. We and others1-10 have noted failures of endograft
limbs in patients after endovascular AAA repair. We sought
to investigate which design features could be identified as
contributors to patency of endovascular graft limbs.
METHODS
We reviewed the records of patients who had under-
gone endovascular AAA repair and femorofemoral bypass
grafting at a single institution, and the information was
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Objective: Endovascular abdominal aortic aneurysm (AAA) grafts are subject to subsequent failure of endograft limbs.
We sought to determine what device-related factors could be identified that might contribute to limb failure.
Methods: We reviewed the records of patients who had undergone endovascular AAA repair and femorofemoral bypass
grafting at a single institution.
Results: Endovascular AAA repair was performed in 173 patients. There were 137 bifurcated endografts and 36 aor-
tomonoiliac grafts combined with femorofemoral bypass grafts, yielding a total population of 310 aortic graft limbs and
36 femorofemoral grafts. Thirty-nine additional patients underwent femorofemoral bypass grafting for occlusive disease.
The cumulative primary patency of all endografts performed for AAA was 92% at 21 months. Secondary patency was
achieved for all failed endograft limbs. There were 24 aortic graft limb “failures” that required intervention: seven limbs
underwent thrombosis requiring revision; kinked limbs requiring stenting either at the time of graft placement (17) or
subsequently (7) were identified. Fully supported endograft limbs had better primary patency (97% at 18 months) than
unsupported limbs (69% at 18 months, P < .001). The aortomonoiliac grafts with femorofemoral bypass grafts tended to
have better patency (97% at 18 months) than bifurcated endografts (90% at 18 months), but this did not reach statistical
significance (P = .28, not significant). Femorofemoral grafts performed for occlusive disease were found to have somewhat
lower patency than those performed for AAA (83% vs 92% at 18 months of follow-up, P = .37, not significant).
Conclusions: Fully supported AAA endografts provide superior endograft limb patency compared with unsupported
designs. Consideration should be given to routine stenting of all unsupported endograft limbs. Aortomonoiliac grafts and
bifurcated grafts provide similar results for endograft limb patency. Femorofemoral bypass grafts performed in conjunc-
tion with aortomonoiliac grafts for AAA disease provide excellent short-term patency. (J Vasc Surg 2001;33:296-303.)
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ported graft limb system. The mean length of follow-up
was 9.7 months (range, 1-26 months). Overall primary
patency of aortic endograft limbs was 92% at 24 months.
The patency rate by graft type and configuration is shown
in Table I. Secondary patency was achieved for all failed
limbs.
During the follow-up interval there were 24 endograft
limbs that required intervention (Table II) to maintain or
restore patency (17 Ancure EVT, 7 World Medical
Talent). Of these, 17 limbs with stenoses or kinks noted
on arteriography at the time of graft placement underwent
primary stenting to achieve assisted primary patency (Fig
1), resulting in an assisted primary patency rate of 97% at
18 months. The remaining seven limbs thrombosed in
later follow-up (4 Ancure EVT, 3 World Medical Talent).
Presentation at the time of thrombosis was an acute onset
of pain and paresthesias with loss of femoral pulse but
intact sensory and motor function (6) or an acute onset of
paralysis with loss of sensation (1). All patients presented
within 24 hours of their thrombotic event. Of these seven
thrombosed endografts, patency was restored with throm-
bolysis and stenting (4) or surgical thrombectomy fol-
lowed by stenting (2) (Fig 2). Balloon angioplasty and
stenting without the need for thrombolysis or thrombec-
tomy reopened one occluded limb. There were no long-
term ischemic sequelae of thrombosed limbs and no
amputations. The underlying lesions that narrowed or
kinked the graft limbs and that were thought to be
responsible for limb failure were located at the aortic
bifurcation (9) or in the iliac arteries (9). All grafts treated
with thrombolysis cleared thrombus completely within 24
hours of initiation of treatment.
Femorofemoral bypass graft for occlusive disease
Over the interval studied, 39 patients underwent femo-
rofemoral bypass grafting for arterial occlusive disease. The
mean patient age was 68 years (range, 42-86 years). There
were 30 men and nine women. All grafts were made of
externally supported polytetrafluoroethylene. Graft diame-
ters were either 8 mm (32) or 7 mm (7). Inflow was from
the native iliofemoral circulation in 34 patients, six of
whom had undergone preliminary percutaneous angio-
plasty with or without stenting of the inflow vessel. For five
patients, femorofemoral graft inflow was based on another
bypass graft: axillofemoral (1), aortofemoral (2), or thora-
cofemoral (2). Additional outflow procedures were per-
formed in conjunction with the femorofemoral graft in
eight patients (4 femoropopliteal, 4 femorotibial). Graft
infections that required graft removal occurred in three
patients. Life-table primary graft patency was 83% at 18
months. The primary patency (Fig 3) of femorofemoral
bypass graft performed in conjunction with aortomonoiliac
endografting for aortic aneurysm disease was better at 18
months follow-up (92%) than for femorofemoral bypass
grafts performed for occlusive disease (83%), but this dif-
ference was not statistically significant (P = .37).
Group comparisons of endograft limbs
Aortomonoiliac versus bifurcated aortic endo-
grafts. The primary patency of aortomonoiliac graft limbs
was 97% at 18 months, and for bifurcated graft limbs, it
was 90% (P = .28; Fig 4). If the patency of the femoro-
femoral graft necessitated by aortomonoiliac graft design
was taken into account, then overall patency for patients
undergoing this latter procedure was 95% at 18 months,
Table II. Endovascular graft limb failure: source and treatment
Lesion at Mechanical Thrombolytic
Device type (no.) Configuration aortic bifurcation Lesion in iliac thrombectomy therapy
Ancure E.T. (17) Bifurcated 8 3 1 2
World Medical Talent (6) Bifurcated 1 5 1 2
World Medical Talent (1) Aortoiliac 0 1 0 0
Twenty-four limb failures (17 intraoperative and 7 postoperative) are summarized according to device manufacturer and configuration of failed limbs and
the location of the underlying lesion held responsible for the limb failure. All lesions were successfully treated with balloon angioplasty and stenting.
Table I. Patency of endograft limbs*
Device type Assisted
(no. of limbs) Configuration Primary patency primary patency
World Medical Talent (156) Bifurcated 96% 98%
World Medical Talent (33) Aortoiliac 97% 100%
Ancure EVT (56) Bifurcated 69% 91%
Ancure E.T. (3) Aortoiliac 100% NA
Medtronix AneuRx (50) Bifurcated 100% NA
Baxter Lifepath (8) Bifurcated 100% NA
Cook Zenith (4) Bifurcated 100% NA
*Secondary patency was achieved for all failed limbs.
NA, Not applicable.
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which was not significantly different than bifurcated graft
patency (P = .37).
Supported versus unsupported endograft limbs.
The primary patency of supported limbs was 97%, and the
assisted primary patency was 99% at 18 months (Fig 5).
Unsupported limbs had a primary patency of 69% (P <
.001) and an assisted primary patency of 91% (P = .01) at
18 months.
Supported graft design comparison. No significant
difference in patency at 18 months was identified among
fully supported graft limbs when compared by the manu-
facturer (Medtronics/AneuRx vs World Medical/Talent
vs Baxter/Lifepath vs Cook/Zenith).
DISCUSSION
The use of endovascular repair of AAAs is rapidly pro-
Fig 1. Assisted primary patency with stenting of unsupported graft limbs intraoperatively. A, Intraoperative arteriogram performed with
a marker catheter (1-cm calibrations) before unsupported graft deployment shows the aortic and left common iliac artery aneurysms.
After uneventful graft deployment, a completion arteriogram (B) shows no flow into the left limb of the bifurcated graft (note presence
of embolization balloon previously placed in left hypogastric artery). Placement of a Wallstent (14 × 40 mm) into left limb restored its
patency but caused right limb to fail by compressing it at aortic bifurcation; thus both limbs were fully stented (plain x-ray film show-
ing stents in limbs [C]) to obtain assisted primary patency (final arteriogram [D]).
A B
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liferating. The technology is quickly evolving, but as yet,
no clear consensus has emerged with regard to which
device design features are optimal. Currently, grafts are of
either bifurcated or aortomonoiliac designs, the latter type
requiring a femorofemoral bypass graft for contralateral
limb and pelvic perfusion. Bifurcated grafts can be in the
form of a single body design or a composite of modular
components assembled within the patient. The limbs of
the endografts can be made of various fabric materials and
may or may not be supported by a skeleton of internal or
external stents.
We and others have noted the failure of endograft
limbs in patients immediately on insertion or at a later
time, resulting in limb ischemia.1-10 Chuter et al5 noted a
30% incidence of stenoses in their study of bifurcated,
unsupported limbs that were readily treated with stents. In
the current report, we noted that all limb failures were
attributable to mechanical causes. Kinks or stenoses were
noted either on completion arteriograms or on arteri-
ograms performed after the removal of thrombus from the
failed endograft limb. These stenoses and kinks were treat-
able with endovascular methods of angioplasty and stent-
ing in all cases and did not require the placement of
surgical bypass grafts or conversion of the endovascular
AAA repair to an open procedure.
The stenotic areas themselves were located in regions
of tortuosity or narrowing in the arteries in which the
endografts were constrained. Iliac tortuosity or occlusive
disease frequently contributed to limb failure but was eas-
ily remedied by balloon angioplasty and stenting. These
regions of tortuosity and narrowing can compromise
grafts by direct extrinsic compression of the limb or by
providing a friction point for introduction of twists, par-
ticularly in unsupported graft limbs. Another important
site of stenoses we identified was the aortic bifurcation,
where several possible mechanical features may contribute
to the development of narrowing. First, the angulation of
the bifurcation in relation to the course of the iliac artery
can introduce kinking. Additionally, the bifurcation, which
can be relatively narrowed compared with the large diam-
eter of the aortic aneurysm, can become a friction point or
fulcrum for the graft to bend or twist. Also, luminal
thrombus within the aneurysm, which jackets the limb,
can cause extrinsic limb compression. Finally, in bifurcated
systems, two limbs must pass through the aortic bifurca-
tion. If this region is the same (or less) diameter as the sum
of the diameters of the individual limbs, there will be com-
pression of one or both limbs. We found that in such sit-
uations, the stenting of both limbs with a “kissing”
technique was essential. When the kinking is noted to be
at the aortic bifurcation level, the treatment of only one
limb may result in subsequent failure of the untreated con-
tralateral limb either immediately or subsequently (Fig 1).
Secondary patency of all thrombosed limbs was
achieved. We prefer thrombolytic therapy for this situation
and have used tissue plasminogen activator infusions, as
have others.3,9 Mechanical thrombolysis with a balloon
catheter is hazardous, and there is a high risk of dislodg-
ing the endograft limb, which in many cases is held in
place only by the radial force of the self-expanding stents.
Fig 2. Secondary patency of thrombosed endograft limbs was achieved with mechanical or chemical thrombolysis. The patient shown
had received an unsupported bifurcated graft 5 days before readmission for an acutely ischemic right leg. At the initial procedure, a
Wallstent was required for left endograft limb to achieve assisted primary patency. Aortography (A) revealed a thrombosed right endo-
graft limb. Selective right limb injection showed multiple stenotic regions and thrombus (B), which were treated with catheter-directed
thrombolytic therapy. The limb was subsequently stented to maintain patency.
A B
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This may be necessary, however, in situations where
thrombolytic therapy is contraindicated. We have reserved
mechanical thrombolysis for patients who have acute,
limb-threatening ischemia as a consequence of their limb
thrombosis and for patients who have recent wounds that
would not allow safe thrombolysis without the risk of
hemorrhage from arteriotomy sites. We have not had to
resort to placement of femorofemoral or axillofemoral
bypass grafts, but these would remain as reasonable extra-
anatomic alternatives to direct treatment of failed limbs.
Our unsupported grafts had significantly lower pri-
mary and assisted primary patency rates when compared
with their fully supported counterparts. Others have noted
this trend as well. In the Ancure data (unsupported limbs)
presented to the Food and Drug Administration summa-
rizing results from 242 patients, a 38.4% incidence of
decreased limb flow was noted, and in another study of 77
patients with Ancure (unsupported limb) grafts, a 37.7%
incidence of decreased limb flow due to stenoses was
described.11 Unsupported limbs are used for traditional
open aneurysm surgery, but these limbs are not con-
strained within a tortuous, diseased, or acutely angulated
iliac system. In open procedures, great care is taken, under
direct vision, to avoid twists or kinks. This is not possible
with the endovascular approach in which a remote deliv-
ery system is used. Although arteriography is routinely
used at the completion of endovascular aneurysm proce-
dures, others have described the use of intravascular ultra-
Fig 3. Femorofemoral bypass graft patency comparison for patients with occlusive disease versus patients with aortic aneurysm disease
in conjunction with aortomonoiliac endograft. Primary patency at 18 months was 92% for aneurysm patients and 83% for occlusive dis-
ease patients (P = .37).
Fig 4. Comparison of patency of endograft limbs: bifurcated versus aortomonoiliac designs. Primary patency of bifurcated graft limbs
at 18 months was 90%, and aortomonoiliac limbs was 97% (P = .28). Secondary patency was achieved in all cases.
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sound scan, which they believe to be more sensitive for
detection of limb narrowing.12
The use of fully supported graft limbs provides
improved patency compared with the use of unsupported
limbs. In a large study of fully supported endografts, no
kinks or stenotic lesions were noted in the follow-up inter-
val.13 We and others currently make liberal use of supple-
mental stents for unsupported limbs.5,6,8,9 We have found
that a satisfactory arteriographic appearance, free of kinks
or stenoses, can still result in a thrombosed limb in longer
follow-up because of development of kinks at a later time.
Of those patients who presented with late limb throm-
boses, four were found to have aortic bifurcation kinks,
and three had iliac lesions that were not apparent at the
time of graft placement. It is suspected that these kinks
were induced by changes in configuration subsequent to
placement. We have never seen a thrombosed limb that
did not prove to have an identifiable kink or stenotic lesion
after thrombectomy or thrombolysis. Perhaps these limbs
elongate with time, leading to later kinking, or perhaps
with subsequent conformational changes in the aneurysm
shell (shrinkage), the geometry of the limbs changes,
resulting in the development of kinks. It is hoped that sup-
porting the limb with stenting will guard against later
problems with limb stenoses. Despite the additional time
and cost incurred, consideration should be given to rou-
tine prophylactic stenting of all unsupported limbs.
There are advantages to the unibody, unsupported
design, when compared with fully stented endograft limbs,
which should not be overlooked. Although these grafts are
prone to kinking over time, the single-piece configuration
guards against separation of modular graft limb compo-
nents that may occur as the aneurysm shell shrinks. This lat-
ter phenomenon has been described and has led to late
endoleak and subsequent aneurysm rupture.14 The stenting
of limbs is not without risk, because the friction between the
graft limb stents and the fabric of the endograft may lead to
erosion of the fabric-producing late endoleaks.15
We found no significant difference in the patency of
endograft limbs related to the choice of aortomonoiliac
versus bifurcated endograft design. This held true even
when patency of the femorofemoral bypass graft necessi-
tated by the former choice was taken into account. The
choice of configuration is chiefly dictated by the patient’s
anatomic features. Many patients have only one iliac sys-
tem that can adequately accommodate passage of the aor-
tic graft delivery system because of occlusive disease or
tortuosity. Such patients would not be candidates for
bifurcated grafts, and aortomonoiliac grafting with femo-
rofemoral bypass graft is an attractive alternative.
Additionally, patients who have short “landing zones” in
the common iliac artery may be better served with
embolization of the common iliac artery and retrograde
perfusion of the hypogastric artery through a femoro-
femoral bypass graft to avoid pelvic ischemia, rather than
with covering the hypogastric artery with a bifurcated
graft limb. Also, the previously mentioned situation of a
narrow aortic bifurcation that cannot comfortably accom-
modate the passage of two side-by-side bifurcated limbs is
an indication for the use of an aortomonoiliac design.
Recently, aortomonoiliac grafts have been suggested as a
ready endovascular alternative for patients presenting with
ruptured aneurysm.16 In this emergency situation there is
no time for the imaging and measurements required for
planning a bifurcated graft design. Our experience sug-
gests that the choice of aortomonoiliac grafting is a rea-
sonable alternative compared with bifurcated designs. The
risk of infection of the femorofemoral graft, not patency,
seems to be the chief drawback to this approach.
Although we noted slightly higher patency rates in
femorofemoral bypass grafts performed in conjunction
with aortomonoiliac endografts than in those femoro-
Fig 5. Comparison of patency of endograft limbs: supported (thick line) versus unsupported (thin line) designs. Primary patency of sup-
ported graft limbs at 18 months was 97% and unsupported limbs 69% (P < .001). Assisted primary patency (not shown) for supported
limbs was 99% and unsupported 91% (P = .01). Secondary patency was achieved in all cases.
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femoral bypass grafts performed for occlusive disease,
this finding was not statistically significant. In a larger
series, Walker et al17 have also shown excellent patency
rates in femorofemoral bypass grafts performed in con-
junction with aortomonoiliac endografts. We had only
one thrombosed graft (and one infected graft that was
removed), providing a patency rate of 92% at 18 months.
We suspect that in the long term, grafts performed for
aneurysm disease will prove to have better patency rates
than those performed for occlusive disease because of the
relative absence of outflow tract occlusive disease in the
aneurysm population compared with the occlusive dis-
ease population. Infection continues to be the main
drawback of the procedure.
The nonrandomized nature and relatively short mean
follow-up interval of our study limit its conclusions. Most
of our patients were participants in clinical trials of the
devices used and subject to the selection criteria unique to
each trial. As devices become generally available, direct
comparisons of graft designs should be possible, leading to
a better understanding of design features that are most
likely to result in durable endovascular repairs of AAAs.
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DISCUSSION
Dr James May (Sydney, Australia). This interesting report
from the University of Pennsylvania School of Medicine is based
on a large experience of endoluminal repair of AAA in 173
patients. The major finding of this study that fully supported AAA
endografts provides superior endograft limb patency compared
with unsupported designs adds a scientific basis to what has been
suspected on an anecdotal basis for some time.
I have some reservations about the study design and analysis.
The first concerns the definition of graft limb failure. While there
is no problem labeling the seven patients whose limbs throm-
bosed in later follow-up as graft limb failures, it seems unreason-
able to refer to intraoperative blood flow problems in the same
way. This seems analogous to counting the successful placement
of a cuff or extension to treat extravasation of contrast at the orig-
inal operation as an endoleak and calling this a failed procedure.
The kinks or stenoses that were noted at operation may just as
well have been caused by twisting in a unibody prosthesis or a
technical error in the deployment process as some intrinsic fault
in the design of the graft limbs. In this study the cause of graft
limb failure has been attributed to the lack of full metallic support
in the limbs. Since the majority of graft limb failures occurred in
endografts that were both unibody and lacking in full support,
there is no way of apportioning the blame.
The second reservation concerns the validity of analyzing the
two groups together since their etiology is quite different. In one
group of seven patients the limbs were found to be satisfactory on
postprocedure angiography and subsequently occluded in later
follow-up. In the other group of 17 patients, the problem was
part of the original procedure rather than failure in follow-up. In
the first group there were no kinks or stenoses noted, while these
were always found in the second group.
I have four questions for the authors.
What was the relative incidence of narrowing of the distal
aorta compared with pathology in the iliac arteries as possible eti-
ological factors in graft limb failure?
Secondly, do the authors feel that the use of either on-table
biplanar postprocedure angiography or predischarge duplex scanning
and plain x-ray would reduce the incidence of graft limb failure?
Thirdly, what technique was used for the thrombolysis of the
occluded limbs? Where are the catheters placed, and what was the
approximate duration of the treatment?
And finally, will the authors comment on the ethics and cost
of using a device that has a predictable requirement of two addi-
tional self-expanding stents in a high proportion of cases?
Thank you. 
Dr David G. Neschis. Thank you, Dr May.
We agree with you completely with regard to the shortcom-
ings in the evaluation and the definitions, but I think it doesn’t
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detract from the fact that these grafts do behave differently. A
major point of this discussion is that the unibody designs do
behave differently and have to be treated differently intraopera-
tively, although the final outcome can be excellent.
As far as imaging in the OR, in particular with the unibody
designs, we’ve become very meticulous with imaging in multiple
planes. And what we’ve developed is a very low threshold for
stenting bilaterally if the views aren’t perfect in multiple planes.
As far as lysis, it’s performed by our interventional radiolo-
gists. They’re using t-PA now. The catheter is placed directly in
the clot. Usually the first run is for about 6 hours, and then
depending on the result, it’s continued. But generally, they don’t
like to go beyond 24 hours.
As far as using a device that we know requires a secondary
intervention, we really don’t have a problem with that because, as
we mentioned in the talk, it’s quite possible that the advantages of
a unibody design may be sufficient to justify the added expense.
Dr James F. McKinsey (Chicago, Ill). I enjoyed your presen-
tation.
Your follow-up, as best I could tell, was 21 months at maxi-
mum length. And I think one question we also have to ask is long
term, for these more fully supported grafts. As we have changes
in the morphology of the aneurysm sac with exclusion, are they
going to be more predisposed to kinking than the unibody con-
struction, not fully supported or augmented with the more flexi-
ble Wallstent if that’s what you’re using? Have you seen this as
sequelae in your follow-up, and are you using the Wallstent for
your support?
Dr Neschis. To answer your second question, yes, we support
the unibody design grafts with the Wallstent.
We haven’t seen too many long-term failures, but we have
seen limb failures in the fully supported limbs as well. Potentially,
we may even bias against the fully supported limbs because some
of them, particularly the AneuRx device, come on a smaller intro-
ducer. And so in patients with some degree of iliac disease, we
may be biasing towards the introducer size as opposed to the
device. In otherwise good anatomy but tortuous iliac vessels, if
we could, we would use the unibody unsupported.
Dr Evan C. Lipsitz (Bronx, NY). Just a quick question.
You’ve answered it partially with your use of biplane angiography
and a low threshold for Wallstenting, but do you also use pressure
gradient measurements or any other intraoperative techniques to
help you decide whether to stent these unsupported limbs intra-
operatively?
Dr Neschis. Absolutely. If there’s any question, we do measure
pullback pressures. But we’ve been burned in that situation as
well. So it doesn’t guarantee success postoperatively.
Dr David C. Brewster (Boston, Mass). I rise to emphasize one
mechanism of endograft limb failure as it relates to time. We, as
many other groups, have had either periprocedural or early post-
operative problems with unsupported graft limbs and flow
obstruction. However, all of our late limb failures have in fact been
in supported limb grafts that have more difficulty accommodating
to morphologic changes of the shrinking AAA sac, what I refer to
as the so-called “paradox of success.” That is, problems due to
kinking of stented graft limbs may occur due to the very same out-
come one desires: exclusion and diminishment in AAA size.
Therefore, in the long term, unsupported limbs may actually
accommodate better to such late morphologic alterations.
Dr Neschis. I agree. In general, even in the later failures, there
has been some definable lesion that was able to be addressed; usu-
ally in that setting it’s kinking.
